UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report: January 21, 2009
(Date of earliest event reported)
TENET HEALTHCARE CORPORATION
(Exact name of Registrant as specified in its charter)
Nevada | 1-7293 | 95-2557091 | ||
(State of Incorporation) | (Commission File Number) | (IRS Employer Identification Number) |
13737 Noel Road
Dallas, Texas 75240
(Address of principal executive offices, including zip code)
(469) 893-2200
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 | Other Events |
Tenet Healthcare Corporation (the Registrant) has reclassified certain financial information previously reported in its Annual Report on Form 10-K for the year ended December 31, 2007 (the Form 10-K), which was filed with the Securities and Exchange Commission (SEC) on February 26, 2008, from continuing operations to discontinued operations. The reclassification has no impact on total assets, liabilities, shareholders equity, net loss or cash flows provided by (used in) operating, investing and financing activities.
The reclassifications described below have been made to update the financial information included in the Form 10-K to present such financial information on a basis consistent with the Registrants Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2008, which was filed with the SEC on November 4, 2008.
The consolidated financial statements, including the notes thereto, for the years ended December 31, 2007, 2006 and 2005, as set forth in Item 8. Financial Statements and Supplementary Data of Exhibit 99.1, have been revised to reflect in discontinued operations the following six facilities: Community Hospital of Los Gatos; Garden Grove Hospital and Medical Center; Irvine Regional Hospital and Medical Center; San Dimas Community Hospital; USC Kenneth Norris Jr. Cancer Hospital; and USC University Hospital, all in California.
Based on sales or current plans to divest these hospitals, U.S. generally accepted accounting principles require that the results of operations of the hospitals be classified in discontinued operations on a retroactive basis in this filing and any future filings.
Item 6. Selected Financial Data and Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations have also been revised to conform to the presentation of the reclassified consolidated results of operations. Except for Note 4 to the consolidated financial statements, no part of Exhibit 99.1 has otherwise been updated to reflect events subsequent to the filing of the Form 10-K.
The attached information should be read together with the Form 10-K and the Registrants SEC filings subsequent to the Form 10-K, including its Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.
Item 9.01 | Financial Statements and Exhibits |
(d) | Exhibits |
Exhibit No. |
Description | |
23.1 | Consent of Deloitte & Touche LLP | |
23.2 | Consent of KPMG LLP | |
99.1 | Reclassified Financial Information |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
TENET HEALTHCARE CORPORATION | ||||||
Date: January 21, 2009 | By: | /S/ BIGGS C. PORTER | ||||
Biggs C. Porter | ||||||
Chief Financial Officer | ||||||
Date: January 21, 2009 | By: | /S/ DANIEL J. CANCELMI | ||||
Daniel J. Cancelmi | ||||||
Vice President and Controller |